Sensus Healthcare (NASDAQ:SRTS) Share Price Passes Below 50 Day Moving Average - Here's What Happened

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report)'s stock price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $5.63 and traded as low as $4.57. Sensus Healthcare shares last traded at $4.77, with a volume of 130,239 shares.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. HC Wainwright increased their target price on Sensus Healthcare from $11.00 to $12.00 and gave the company a "buy" rating in a research report on Monday, February 10th. Lake Street Capital decreased their price target on shares of Sensus Healthcare from $18.00 to $13.00 and set a "buy" rating on the stock in a research note on Tuesday, March 11th.

Sensus Healthcare Trading Down 0.8 %

The firm has a market capitalization of $78.02 million, a P/E ratio of 11.83 and a beta of 1.28. The firm has a 50 day moving average price of $5.63 and a 200-day moving average price of $6.55.

Sensus Healthcare (NASDAQ:SRTS - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.09 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.01). Sensus Healthcare had a return on equity of 12.60% and a net margin of 15.90%. Research analysts anticipate that Sensus Healthcare, Inc. will post 0.32 earnings per share for the current year.

Remove Ads

Institutional Trading of Sensus Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SRTS. JPMorgan Chase & Co. bought a new position in shares of Sensus Healthcare during the fourth quarter valued at approximately $27,000. Barclays PLC purchased a new position in Sensus Healthcare during the 4th quarter valued at $35,000. BNP Paribas Financial Markets bought a new position in Sensus Healthcare in the 4th quarter valued at $47,000. IFP Advisors Inc purchased a new stake in Sensus Healthcare in the fourth quarter worth $95,000. Finally, NewEdge Advisors LLC bought a new stake in shares of Sensus Healthcare during the fourth quarter worth $109,000. 25.30% of the stock is owned by hedge funds and other institutional investors.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.